Provectus Biopharmaceuticals Issues Going Concern Warning Following Q1 2026 Loss Renatus RTAC Stalls at 1041 Breakout or Breakdown 20260519 Solid Power SLDP Reports Strong Q1 2026 Revenue NA EPS Beats